Nisa Investment Advisors
HBIO icon

Nisa Investment Advisors’s Harvard Bioscience HBIO Stock Holding History

Nisa Investment Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11K Sell
228
-1
-0.4% -$6 ﹤0.01% 2729
2025
Q4 		$1.53K Hold
229
– – ﹤0.01% 2653
2025
Q3 		$1K Hold
229
– – ﹤0.01% 2747
2025
Q2 		$1.02K Buy
229
+177
+340% +$740 ﹤0.01% 2734
2025
Q1 		$297 Sell
52
-9
-15% -$115 ﹤0.01% 2873
2024
Q4 		$1.29K Buy
61
+58
+1,933% +$1.33K ﹤0.01% 2611
2024
Q3 		$83 Sell
3
-10
-77% -$295 ﹤0.01% 2917
2024
Q2 		$382 Buy
+13
New +$456 ﹤0.01% 2737

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's HBIO Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Harvard Bioscience (HBIO) stake by 0.44% in Q1 2026, selling an estimated $6 and leaving 228 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Nisa Investment Advisors first reported a position in HBIO in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.53K in Q4 2025. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Nisa Investment Advisors held 228 shares of Harvard Bioscience worth $1.11K as of Q1 2026.
  • Nisa Investment Advisors sold 1 Harvard Bioscience share in Q1 2026, an estimated $6.
  • Harvard Bioscience made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2729 holding.
  • Nisa Investment Advisors first reported a position in Harvard Bioscience in Q2 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Harvard Bioscience position peaked at $1.53K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.